Latest Publications

Mihalchik AL, Roberts A, LaCombe J, Lloyd M, Doepker C, Eapen A. 2026. Evaluation of the safety and potential genotoxicity of a high-purity mogroside ingredient containing siamenoside I produced from a modified strain of Yarrowia lipolytica. Toxicol Rep 17(Dec):102297; doi: 10.1016/j.toxrep.2026.102297. PMID: 42388455.

View Abstract

Marden E, Jacobs KM, Doepker C. Science, safety, and chemical risk. General Session 6, Consumer Healthcare Products Association (CHPA) Regulatory and Scientific Affairs Conference (RSQ), Rockville, MD, September 30, 2026.

View Abstract
BlueRidge Life Sciences Companies